论文部分内容阅读
目的比较海捷亚和苯那普利对原发性高血压的治疗效果。方法选择2006年7月至2007年8月在本院治疗的60例原发性高血压患者,随机分为观察组和对照组,分别采用海捷亚和苯那普利治疗,比较两组治疗效果和不良反应发生情况。结果观察组显效率为70%,有效率为23.3%,总有效率为93.3%;对照组显效率为40%,有效率为33.3%,总有效率为73.3%,两组比较差异有统计学意义(P<0.05),观察组疗效要优于对照组;观察组有3例患者出现不良反应,无干咳病例出现;对照组有8例患者出现不良反应,干咳发生率明显高于观察组(P<0.05)。结论海捷亚降压效果优于苯那普利,且不良反应较少,值得在临床推广应用。
Objective To compare the therapeutic effect of Hytera and benazepril on essential hypertension. Methods Sixty patients with essential hypertension who were treated in our hospital from July 2006 to August 2007 were randomly divided into observation group and control group. The patients were treated with Hydergine and benazepril respectively. Effects and adverse reactions occurred. Results The effective rate was 70%, the effective rate was 23.3% and the total effective rate was 93.3% in the observation group. The effective rate was 40.3%, the effective rate was 33.3% and the total effective rate was 73.3% in the observation group. The difference between the two groups was statistically significant (P <0.05). The curative effect in the observation group was better than that in the control group. In the observation group, 3 patients had adverse reactions and no dry cough occurred. In the control group, 8 patients showed adverse reactions and the incidence of dry cough was significantly higher than that in the observation group P <0.05). Conclusions Hayeia is better than benazepril in lowering blood pressure and has fewer adverse reactions, which is worthy of clinical application.